Litigation Watch: ARTHRITIS DRUGS is a monthly newsletter for attorneys, focusing on drugs used to treat osteo and rheumatoid arthritis: Arava, Enbrel, Remicade, Humira, Vioxx, Celebrex and more. These drugs are already the subject of litigation following claims that they cause everything from liver damage to cancer, heart failure and strokes. Each issue features case news, interviews, legislative and FDA updates, and reviews from current medical literature.
Arthritis Drugs - Issue: 24
Merck Seeks to Vacate Ernst Verdict, Says Plaintiff Relied on 'Junk Science'
New Vioxx Study Finds Cardiovascular Risk Highest in First Two Weeks
Merck Says Causation Testimony Properly Excluded, Opposes Second Retrial
Vioxx MDL Judge Finds Merck Wrongfully Asserted Privilege over Documents
Arthritis Drugs - Issue: 23
Arthritis Drugs in the Medical Literature This Month - April 2006
Arthritis Drugs - Issue: 24
Jury Finds Merck Liable for Texas Man's Fatal Heart Attack
Next Federal Vioxx Plaintiff Drops Lawsuit after Judge Denies Continuance
Vioxx Plaintiff Opposes Physicians' Renewed Motion to Dismiss
